COVID-19 vaccine trials should seek worthwhile efficacy

Lancet. 2020 Sep 12;396(10253):741-743. doi: 10.1016/S0140-6736(20)31821-3. Epub 2020 Aug 27.

World Health Organization Solidarity Vaccines Trial Expert Group:
N E Dean, M E Halloran, Y Huang, T R Fleming, P B Gilbert, V DeGruttola, H E Janes, P R Krause, I M Longini, M C Nason, R Peto, P G Smith, A X Riveros, P S Gsell, A M Henao-Restrepo

¹ Center for Biologics Evaluation and Research, US Food and Drug Administration, Washington, DC, USA.
² Fred Hutchinson Cancer Centre, University of Washington, Seattle, WA, USA.
³ Department of Biostatistics, College of Public Health and Health Professions College of Medicine, University of Florida, Gainesville, FL, USA.
⁴ Health Emergencies Programme, World Health Organization, CH-1211 Geneva 27, Switzerland. Electronic address: henaorestrepoa@who.int.
⁵ Nuffield Department of Population Health, University of Oxford, Oxford, UK.

No abstract available

MeSH terms